Announcement:

New scientific publication in collaboration with the University of Newcastle on modelling Stargardt disease (STGD1) in vitro with retinal organoids (RO) to unravel genotype-phenotype correlations

Find out more

A man writing something in a notebook

Home › Resources

Resources

Scientific Publications

View all

Unravelling genotype-phenotype correlations in Stargardt disease using patient-derived retinal organoids

Comparison of the Impact of VRP-034 and Polymyxin B upon markers of Kidney Injury in Human Proximal Tubule Monolayers In Vitro

Keith Pye, Elena Tasinato, Siannah Shuttleworth, Claire Devlin and Colin Brown

Development of a Highly Differentiated Human Primary Proximal Tubule MPS Model (aProximate MPS Flow)

Francesca Pisapia, Donovan O'Brien, Elena Tasinato, Kathryn L. Garner and Colin D.A. Brown

Posters

Utilization of high – content imaging for the study of lung fibrosis

High content imaging (HCI) assays enable the study of the fibrotic processes: fibroblast – to – myofibroblast transition (FMT) and epithelial – to – mesenchymal transition (EMT)

The aProximateTM model for renal drug safety/efficacy and transporter studies

Fact Sheets

Ciliary beat frequency analysis assay for lung small airway epithelium cells (SAEC)

iPSC-derived Retinal Pigment Epithelium (RPE)

iPSC-derived Retinal Organoids (RO)

Press releases

View all

Newcells Biotech

Newcells Biotech strengthens executive and US team with key appointments

Scientific eBooks and Protocols

Lung models eBook

aProximate™ Assay-Ready Plates User Guide Cover.

aProximate™ Assay-Ready Plates (Human, 96-well) User Guide

The front cover of the retinal organoid ebook

Retinal Organoids eBook

Q&A with our scientists

Dr Fiona Leslie

Meet the scientists: Dr Fiona Leslie, the scientist behind the development of the advanced FMT assay

Meet the scientists: Anusha Gupta, the scientist behind the development of the CBF assay

Dr Colin Brown face inside cells

The inside story of the development of Newcells’ MPS flow model: Scientific chat with Dr Colin Brown

Videos and Webinars

Newcells Biotech – Kidney Model Capabilities

Meet Dr Kathryn Garner – Head of Kidney Development

Dr Mike Nicholds – Newcells Offerings

Case Studies

View all

Quantitative Fibroblast-to-Myofibroblast Transition (FMT) studies

Quantitative FMT assay with high content imaging

Find out more

Human Lung Fibroblasts stimulated with TGF-β for 72 hours and immunostained to detect α-SMA, as a measure of extracellular matrix production and deposition.

In vitro evaluation of ocular toxicity and phenotypic rescue

Find out more

Newcells Biotech to develop 3D retinal organoids using hiPSC derived skin cells

In vitro selection of the most relevant species to predict human renal toxicity

Find out more

Evaluation of glomerular ADC toxicity in podocytes

Find out more

Isolated primary podocytes immunostained for cilia

Gene therapy viral vector assessment on retinal organoids

Find out more

Gene therapy viral vector assessment on RPE cells

Find out more

RPE

Predicting human renal injury from antisense oligonucleotide (ASO)

Find out more

Book a Call